Abiopharma

News list

Director DURCAN DERMOT MARK 🟢 acquired 905 shares of Cencora, Inc. (COR) at $359.28 Transaction Date: Mar 05, 2026 | Filing ID: 000002

Full text

News bot March 9, 2026, 8:21 p.m.
🔍 DURCAN DERMOT MARK (Director)

Company: Cencora, Inc. (COR)

Report Date: 2026-03-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 905
Detailed Transactions and Holdings:
- Acquired 905 shares of Common Stock at $359.28 per share (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,767.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.